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Abstract
Background: The main objective of this study is to measure the relationship between morbidity,
direct health care costs and the degree of clinical effectiveness (resolution) of health centres and
health professionals by the retrospective application of Adjusted Clinical Groups in a Spanish
population setting. The secondary objectives are to determine the factors determining inadequate
correlations and the opinion of health professionals on these instruments.
Methods/Design: We will carry out a multi-centre, retrospective study using patient records
from 15 primary health care centres and population data bases. The main measurements will be:
general variables (age and sex, centre, service [family medicine, paediatrics], and medical unit),
dependent variables (mean number of visits, episodes and direct costs), co-morbidity (Johns
Hopkins University Adjusted Clinical Groups Case-Mix System) and effectiveness.
The totality of centres/patients will be considered as the standard for comparison. The efficiency
index for visits, tests (laboratory, radiology, others), referrals, pharmaceutical prescriptions and
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standardization.
The model of cost/patient/year will differentiate fixed/semi-fixed (visits) costs of the variables for
each patient attended/year (N = 350,000 inhabitants). The mean relative weights of the cost of care
will be obtained. The effectiveness will be measured using a set of 50 indicators of process,
efficiency and/or health results, and an adjusted synthetic index will be constructed (method:
percentile 50).
The correlation between the efficiency (relative-weights) and synthetic (by centre and physician) 
indices will be established using the coefficient of determination. The opinion/degree of acceptance 
of physicians (N = 1,000) will be measured using a structured questionnaire including various 
dimensions. Statistical analysis: multiple regression analysis (procedure: enter), ANCOVA (method: 
Bonferroni's adjustment) and multilevel analysis will be carried out to correct models. The level of 
statistical significance will be p < 0.05.
Background
The main factor determining the use of health services is
the pattern of disease of the population, as shown by
many studies in different geographic settings, care levels
and health organization models [1]. In the hospital set-
ting, nearly 20% of the variability in the use of health serv-
ices is explained by the clinical characteristics of the
population attended [2]. In primary health care (PHC),
the explanatory power of the descriptive variables of the
type of disease is still greater and may justify half of the
variability in the use of resources, measured by frequency
(visits or contacts), indirect consumption (referrals to spe-
cialists) and direct costs (diagnostic tests and analyses and
drug prescriptions), rather than age, which is normally
used to adjust resource distribution [3,4].
Patient classification systems (PCS) were introduced more
than 20 years ago in order to measure patient characteris-
tics. Of those developed for the hospital environment,
Diagnosis Related Groups (DRG) are the most widely
reported and used internationally [5]. DRG have been
adopted by most public Spanish health administrations
for planning and management for more than a decade [6].
However, in the PHC setting, these instruments are still in
the research phase in many aspects, although they are
beginning to be used in some regions (Aragon, Catalonia,
Basque Country) as an aid to clinical decision making,
health resource planning, economic distribution and epi-
demiological research, as they allow more reliable and
accurate comparisons to be made between physicians
than demographic population characteristics alone [7].
Of the different systems developed for PHC, Adjusted
Clinical Groups (ACG) [8] is the most widely used.
However some factors still limit the widespread applica-
tion of ACG. These include: 1) technical requirements
(computerized medical records, the normalization and
codification of medical terminology, the level of develop-
ment of the classifications systems themselves and their
validation in geographic and cultural settings and care
models other than those for which they were created); 2)
clinical interpretation of the patient categories identified
by ACG and their potential use in clinical management
and, 3) physician distrust of the application of tools
aimed at objectively measuring and quantifying patterns
of medical practice.
The technical requirements necessary for the application
of ACG have improved substantially. Although not yet a
complete reality, advances in computerizing medical
records in PHC mean large databases in different geo-
graphic settings are now available. In addition, systems
for automatic coding of diagnoses according to the Inter-
national Classification of Diseases (ICD-9-MC) have been
developed.
The team who designed and validated ACG [9] has devel-
oped new methodological approaches to categorizing the
disease types that are closer to the global conception of
the health status of PHC physicians and to the determin-
ing role that chronic disease may play in the use of services
and its clinical management. In addition, predictive mod-
els of utilization have been designed that can identify
population groups who are potentially very-high consum-
ers of resources [10,11], classify the types of patients
attended, and allow cost forecasts to be made. At present,
these are the best-validated method of risk-adjustment in
the Spanish health context.
ACG can be used for more precise and equitable financial
decision-making and evaluate the efficiency of the use of
health resources [12-14]. Currently, in Spain, some man-
agement groups promote the separation of financing, pur-
chasing and provision of services, but require more
accurate instruments to measure care activity. In recent
years, there has been increasing interest in the use of
financing per capita as a mechanism for the allocation of
care resources [15-20].Page 2 of 7
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able to respond to the management needs of PHC: there
is still no normalized Minimum Basic Data Set (MBDS-
PHC) in Spain and there seem to be doubts on the efficacy
of PCS and their adjustment to the characteristics of a
health context different to that for which they were
designed [21].
Generally, the available evidence on the theoretical appli-
cation of ACG is consistent, although there are few reports
on practical application that reinforce this theoretical evi-
dence. Various studies have measured the efficiency of
health centres and physicians adjusted by the burden of
morbidity, although these are case-mix indicators related
to efficiency (cost-adjusted) and do not show whether the
efficiency is associated with perceived or objective health
outcomes. One criticism of PCS is that they do not allow
the effectiveness or power of resolution of PHC teams to
be determined, making them remote from daily clinical
practice. In addition, there are currently no population-
based studies that associate these aspects of efficiency and
effectiveness in terms of management [22].
In Spain, the lack of large, reliable data bases makes this
type of study difficult. Limitations in PHC computer sys-
tems include: a) measurement of total costs per PHC
patient (fixed/semi-fixed and variable), and b) the provi-
sion of indicators for the evaluation of effectiveness (indi-
cators of process, efficiency and evidence-based results)
that measure the variability of clinical practice [11].
The justification of this project is that it will allow our
team to build on their accumulated experience of PCS in
the PHC setting by further refining their scientific consist-
ency and extending it to unknown aspects such as the
organisational behavior and physician profiles with
respect to all resources available in PHC centres (labora-
tory, radiology, diagnostic/therapuetic tests, referrals and
drug prescriptions).
We will attempt to establish and generalize the hypothesis
that an improvement in the use of resources and direct
costs adjusted by case-mix, would result in improvements
in the clinical effectiveness of PHC teams. In addition, the
acceptance of ACG by physicians is essential if clinical
management indictors are to be included in the program-
ming of contracts and could greatly aid decision-making
in health management [23].
Objectives
The main objective of this study is to measure the relation-
ship between morbidity, the direct cost of health care and
the degree of clinical effectiveness of selected Catalonian
PHC centres and physicians by the retrospective applica-
tion of ACG. The secondary objectives include: a) To
determine the factors associated with a deficient correla-
tion between the indices of effectiveness and efficiency
(by PHC centre and physician): b) To determine the
aspects conditioning the development and application of
case-mix adjustment in PHC: c) To explore strategies for
implanting ACG and, d) To determine the opinion of
PHC physicians on the practical utility of case-mix adjust-
ment systems.
Methods/Design
Study design and population
This is a retrospective multicentre study based on the com-
puterized medical records of ambulatory patients and
population data bases in Catalonia, a region in the north-
west of Spain and a population of 7.5 million, within the
framework of a larger Spanish study. The study popula-
tion will consist of people of both sexes attending 15 PHC
centres in Catalonia administered by five providers
(Badalona Serveis Assistencials: Apenins-Montigalá, Mor-
era-Pomar, Montgat-Tiana, Nova LLoreda [2] and ABS La
Riera [2]; Consorci Sanitari Integral: Gaudí, Sagrada
Familia, Torrassa and Collblanc; GesClínic: Les Corts;
Consorci d'Atenció Primària de Salut de l'Eixample: Eix-
ample and Rosselló; PROSS: La Roca del Vallés), with an
assigned population of 350,000 of whom 15.1% are aged
≥ 65 years.
The population is mainly urban, with a lower-middle
socioeconomic level and predominantly engaged in
industry, commerce and services; organization of PHC
teams is modernized, with public management and pri-
vate provision of services concerted with the Catalan
Health Service (Catsalut). Policies on staffing, training
levels, organisation and services offered are representative
of most PHC centres in Catalonia, with decentralized
management and centralized structural services. All
patients demanding care during 2008 will be included;
patients transferring out to other centres, patients from
other regions or countries and those attended by odontol-
ogists during the study period will be excluded. In addi-
tion, it is hoped to obtain information from 1,000
structured interviews with permanent staff (management,
health and nonhealth).
Main measures
Dependent variables will include the mean number of vis-
its, care episodes and total direct costs of PHC care. Addi-
tional variables studied will include: a) general: age, sex,
centre or team, basic activity unit (BAU) and number of
visits carried out, b) total direct costs, c) comorbidity, d)
variables of effectiveness and e) associated factors and
user opinion. Patients will be assigned to medical special-
ties according to age: children aged 0–14 will be assigned
to the pediatric service, and people aged > 14 years to the
family medicine service. A visit will be defined as any con-
tact between PHC teams and a patient in PHC centres or
at home due to a demand for care or a health problem. IfPage 3 of 7
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ity will be ascribed to the physician of record.
Annual coverage (intensity of use) will be defined as the
ratio: patients attended/assigned population. An episode
will be considered as a process of care of a disease or an
explicit patient demand (contact with health services) and
will be quantified according to the International Classifi-
cation of Primary Health (ICPC-2) [24].
Episodes occurring in the study population will be
accounted for by the date of registration in the clinical his-
tory for each episode/reason for consultation, whether
acute or chronic, regardless of the date of initiation of the
diagnostic process. ICPC-2 will be converted (mapped) to
ICD-9-MC by a five-strong working group (one informa-
tion retrieval officer, two clinical physicians and two con-
sulting technicians). The criteria followed will differ
according to whether the relationship between the codes
is null (one to none), univocal (one to one) or multiple
(one to several).
Case-mix measures
The ACG® Grouper version 8 functional algorithm http://
www.acg.jhsph.edu is composed of a series of consecutive
steps which result in 106 ACG, which are mutually-exclu-
sive for each patient attended [8,9]. The construction of an
ACG requires the age, sex and the reasons for consultation
or diagnoses codified according to the ICD-9-MC.
The process of converting ICD-9-MC to ACG consists of 4
stages: the first two group a series of conditions according
to similarity of resource consumption and the second two
combine the most-common groupings: a) ICD-9-MC
diagnoses are grouped into 32 Ambulatory Diagnostic
Groups (ADG), of which a patient may have one or more;
b) ADG are transformed into 12 Collapsed Ambulatory
Diagnostic Groups (CADG); d) CADG are transformed
into 25 Major Ambulatory Categories (MAC); and e) MAC
are transformed into ACG.
This assigns each patient to a resource iso-consumption
group. The method provides the USA mean relative
weights (MRW) of each group with respect to the mean
total cost, providing the resource utilization bands (RUB),
which group each patient into one of five mutually-exclu-
sive categories (1: healthy users, 2: low morbidity, 3: mod-
erate morbidity, 4: high morbidity, and 5: very-high
morbidity) according to morbidity, and the Expanded
Diagnosis Clusters (EDC), which select patients by spe-
cific condition.
This tool allows specific episodes to be identified without
the application of the algorithm of assignation of an ACG.
The population attended will be considered as the stand-
ard (with identical criteria of inclusion and exclusion).
The risk index (RI) reflects the complexity of the diagnoses
attended by a centre with respect to the standard (case-
mix).
The ratio: mean number of visits obtained using ACG/
standard, will be calculated by indirect standardization.
The efficiency index (EI) will be established as the ratio:
number of visits/expected visits for all patients (indirect
standardization). An RI or EI value equal to one signifies
equal complexity or efficiency to the standard (year
2008), whereas an EI < 1 symbolizes greater efficiency
(inverse relation). The relative cost of each ACG will be
obtained by dividing the mean cost of each category by
the mean cost of the reference population. This provides
the MRW of each ACG group with respect to the mean
total cost [8,9].
Model of costs and use of resources
The design of the system of partial costs will be defined
considering the characteristics of the PHC centre, the
information requirements and the degree of development
of the information systems available. The cost per patient
attended during the study period will be taken as the unit
that will serve as a basis for the final calculation.
The adaptation (conciliation or depuration) of expendi-
tures from the profit and loss account of financial
accounting to the costs of analytical accounting will be
carried out in two stages: a) conversion of natural expen-
ditures into costs and b) allocation and classification of
costs. In the first stage, expenditures not directly related to
the productive care process, i.e, financial expenditure,
losses due to fixed assets, exceptional expenditure, stock
variations and provisions for accounting years anterior
and posterior to that studied, will be excluded. In addi-
tion, purchasing of intermediate products unrelated to
radiology and laboratory or diagnostic tests will be
excluded since these are considered variable costs or costs
of productivity.
Natural costs will include the following concepts: staff
(wages and salaries, indemnifications and social security
paid by the company), consumer goods (medicaments,
intermediate products, health material and instruments,
using the formula; cost of purchases – remaining stocks),
and expenditure on external services (cleaning, laundry),
structure (building repair and conservation, clothes, office
material), and management of the centre (write-downs
and taxes). Expenditures will be periodified at the end of
the financial year (accrued income): write-downs of fixed
assets will be based on constant annual depreciation
according to the useful life of the goods according to the
Spanish General Accounting Plan for Health Centres; the
cost of write-downs of capital goods will not be consid-Page 4 of 7
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fied.
The fixed or semi-fixed costs (imputation criterion: indi-
rect costs) and variable costs (imputation criterion: direct
costs) will be considered according to their dependence
on the volume of activity carried out by the centres,. Direct
costs will be considered as those related to physician diag-
nostic and therapeutic requests and referrals.
The study concepts included will be: laboratory (hematol-
ogy, biochemistry, serology or microbiology tests
requested; mean cost per request), conventional radiology
(simple radiology, contrast radiology, ultrasound scans,
mammograms and orthopantomography; tariff per test
requested), medical transport (transfers by ambulance;
mean cost per request), diagnostic tests (digestive endos-
copy, electromyography, spirometry, teleradiography,
computed tomography, audiometry, densitometry,
ambulatory blood pressure, campimetry, stress tests, heart
ultrasound, and others; tariff per test requested), intercon-
sultations (urgent or regular referrals to reference special-
ists or hospitals; adapted tariff per reference),
prescriptions (acute, chronic or on-demand prescriptions
to Catsalut: retail price per package).
The tariffs used will come from the analytical accounting
carried out by PHC centres, invoices of intermediate prod-
ucts issued by the different providers and the prices estab-
lished by Catsalut. Natural expenditures (consumer
goods, external structural and management services) will
be considered as fixed or semi-fixed costs (imputation cri-
terion: indirect costs). Various distribution alternatives to
possible care or non-care cost centres will be evaluated by
primary distribution to the family medicine and pediatric
services of each centre. The mean cost per visit will be cal-
culated and a final direct distribution for each patient will
be made. Therefore, the cost per patient (Cp), according to
the final service assigned will be: Cp = (mean cost per visit
* number of visits [indirect costs]) + (variable costs [direct
costs]). The cost model will not include the costs of spe-
cialized care (hospitalizations, emergency department,
consultations, etc.) or social health (long stay, palliative,
etc.)
Measure of effectiveness
Effectiveness will be defined according to a set of indica-
tors of process and results (differentiated for family med-
icine and pediatric services). A general synthetic index (SI)
will be constituted from the selected indicators. Each indi-
cator will be specifically defined and calculated. The SI
will be calculated by ajdusted rescaling with percentiles
(median; percentile 50) and will be drawn up according
to population-based indicators, chronic disease processes,
health outcomes, efficiency, quality of prescriptions, vac-
cines for risk groups and user complaints. Thirty indica-
tors for family medicine and 20 for pediatrics will be
established.
Final procedure
The adjusted EI of visits, referrals, drug prescriptions and
the total EI will be established, enabling physician profiles
to be drawn up. Posteriorly, the EI and SI will be corre-
lated for each centre and BAU. Subsequently, factors asso-
ciated with PHC centres and physicians with inadequate
indices of efficiency and effectiveness will be quantified
and structured in accordance with the characteristics of
the centres and professional profile.
Physician opinion will be measured using a structured,
anonymous questionnaire containing closed questions
on the dimensions of knowledge, applicability and satis-
faction with ACG in clinical practice.
Power calculation to determine sample size
With an expected synthetic index of 50% and assuming a
random error of 5% (95% confidence interval), a normal
distribution (bilateral contrast) and an estimated preci-
sion of 2‰, the sample size to be recruited will be
240,092 patients. The statistical power of the model will
be 80%.
Statistical analysis
Before the statistical analysis, all data, and especially the
medical histories (OMIAP-WIN programme), will be care-
fully reviewed, observing the distributions of frequency
and searching for possible errors in recording or codifica-
tion. The data will be obtained in computerized form and
the confidentiality of records will be respected at all times
according to Spanish law (LO del 15/1999 de 13 de
diciembre, de Protección de Datos de Carácter Personal,
LOPD).
The study variables will be evalauated using the Kol-
mogorov-Smirnov conformity test. Dependant variables
(direct episodes, visits and costs) will be transformed
using the Naperian logarithm. Depuration of these varia-
bles will be made to establish the cut-off point (T) of
extreme cases (atypical observations) using the formula: T
= Q3+1,5 (Q3-Q1), where Q3 and Q1 are the third and first
quartiles of the distribution, respectively. The explanatory
power of the classification will be calculated using the
ratio: determination of intra-group variance/total. The
homogeneity of variance will be tested using Cochran's
test. The association between quantitative variables will
be evaluated using Pearson's linear correlation and/or
Spearman's rank correlation coefficient. Multiple linear
regression analysis (procedure: enter) and covariance
(ANCOVA; procedure: Bonferroni) will be carried out
according to the recommendations of Tompson and Bar-Page 5 of 7
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multilevel, analysis, where the variables, centre and physi-
cian, will act as components, will be made. The level of
statistical significance will be established as p = .05. The
analysis will be made using the SPSS v12 for Windows
programme.
Approval by the Committee of Ethics and Clinical 
Research
In accordance with Spanish recommendations, the Study
Protocol was approved by the Committee of Ethics of




Phase 1–2. Meeting to decide general planning of the
study.
Tasks will be assigned to investigators and informative
meetings held with physicians from particpating PHC
centres. Posterior followups will be quarterly. A biblio-
graphical and documental search will be made and a
structured summary drawn up.
Phase 3. Obtention of patient variables (quantitative
information). Time: 8 months.
This includes: a) design and drawing up of a morbidity
data base (care episodes attended by patient/year). Time:
1 month; b) design and drawing up pharmaceutical pre-
scription data base (Catsalut). Time: 2 months; c) design
and drawing up direct costs data base (laboratory, radiol-
ogy, referrals and pharmaceutical prescription per patient/
year). Time: 3 months; d) conversion (mapping) of CIAP
to ICD-9-MC. Time: 1 month; and e) obtention of an ACG
per patient/year. Time: 1 month.
2) Second year
- Phase 4. Drawing up of a computer programme for
depuration of dependant variables, using MS Access and
Visual Basic. Time: 1 month.
Phase 5. Drawing up of data base of 50 indicators of effec-
tiveness of clinical practice. Previous bibliographical
search based on evidence available. Time: 2 months.
Phase 6. Unification of quantitative and qualitative data
bases. Time: 1 month.
3) Third year
Phase 7. Design and carrying out of interviews with physi-
cians. Time: 5 months.
Phase 8. Validation of data quality. Verification of univar-
iate results by ranges. Identification of inadequate catego-
ries. Time: 2 months.
Phase 9. Data analysis. Including: a) statistical analysis:
descriptive, bivariate and multivariate; b) analysis of inter-
views: structured questionnaires; and, c) interpretation of
the results. Time: 5 months.
Phase 10. Scientific diffusion of the results: this will
include the writing, translation and publication of the
results obtained. Time: One year.
Data confidentiality
Confidentiality was respected at all times according to
Spanish law (LO del 15/1999 de 13 de diciembre, de Pro-
tección de Datos de Carácter Personal, LOPD).
Discussion
We expect the greatest limitations of the study to be
related to the degree of development of maturity of infor-
mation systems, the accuracy of conversion of ICPC-2 to
ICD-9-MC, the accuracy of the measurement of costs and
the efficiency or possible variability and/or severity in the
selection of the care episode by physicians, which might
lead to contamination between groups or a lack of clinical
specificity. However, these unknown factors may be min-
imized by the large study population we intend to recruit
(regression to the mean). It is expected that the results will
have significant practical applications. The practical char-
acteristics of ACG mean they could become one of the
most-important risk-adjustment intruments in Spain in
the future with respect to the financing of health centres.
It is also expected that the study will have significant
applications in clinical practise.
Firstly, a PCS is used and EI obtained in the visits and the
use of diagnostic tests, referrals and pharmaceutical pre-
scriptions provides a professional profile. Secondly,
knowledge of these EI and their relationship with health
outcomes (SI, effectiveness) is important, not only for
clinical management, but also to allow health profession-
als to learn how well they are working. It is hoped that the
study may permit changes in organisational models with
respect to the optimization of resources (healthy children,
follow-up of chronic diseases, etc.) and improvements in
obtaining information (real time, creation of a corpora-
tive web of the results) and a follow-up of the health out-
comes for physicians. Continuous improvement in these
aspects may result in improvements in overall quality,
with repurcussions in the control of patients. In addition,
according to the results observed, it is hoped that these
indicators may gradually be included in contracts for
health professionals including incentive programmes. ThePage 6 of 7
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of clinical sessions and meetings with management.
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